The ATLS course teaches a clear message on flail chest: identify the paradoxical segment, provide adequate analgesia, and support ventilation as required. For decades, this conservative paradigm has governed how we manage severe chest wall injuries in the acute setting. Yet a quiet revolution has been gathering pace in trauma centres worldwide. Surgical stabilisation of rib fractures (SSRF) - the application of orthopedic reduction and fixation principles to broken ribs - has moved from a niche salvage procedure to an increasingly mainstream intervention. The Chest Wall Injury Society (CWIS) has published updated guidelines, the World Society of Emergency Surgery (WSES) released a major position paper in late 2024, and the American College of Surgeons published new Best Practice Guidelines for chest wall injuries in November 2025. The momentum behind operative rib fixation is undeniable. But the evidence base is far from settled, and the debate about which patients actually benefit - and which may be harmed - is one of the most consequential controversies in contemporary trauma care.
The Scale of the Problem
Rib fractures occur in approximately 10% of all trauma admissions and up to 50% of patients sustaining blunt thoracic trauma. A flail chest - classically defined as fracture of three or more consecutive ribs in two or more places, producing a mechanically unstable segment - occurs in roughly 10% of chest wall injuries and carries a mortality rate exceeding 30% in some series. But the burden of rib fractures extends well beyond the acute phase. A substantial proportion of chest wall trauma survivors - estimated at around one third - will require prolonged rehabilitation, experience chronic pain, and remain functionally disabled for more than six months. An analysis of the National Inpatient Sample Database from 2007 to 2016 calculated average annual costs attributable to rib fractures at 469 million US dollars. The clinical and economic burden is enormous, and the question of whether surgical fixation can meaningfully reduce it has driven a surge in both practice and research.
Where the Evidence Is Strongest: Flail Chest and Ventilated Patients
The case for SSRF in patients with flail chest who are ventilator-dependent is the most robust. Several randomised controlled trials have examined this population. The landmark Canadian multicentre RCT led by Dehghan and colleagues, published in JAMA Surgery in 2022, randomised 207 patients with unstable chest wall injuries to operative or non-operative management. The trial defined instability as three or more fractures with severe displacement, overriding by at least 15 millimetres, protrusion into lung parenchyma, a flail segment, or 25% or greater hemithorax volume loss. In the surgical group, mortality was 0% compared with 6% in the non-operative cohort (p = 0.01). Among ventilated patients specifically, SSRF was associated with improved ventilator-free days and shorter hospitalisation. However, in non-ventilated patients - who constitute the much larger group seen in everyday trauma practice - the benefits were modest at best.
Earlier RCTs by Tanaka (2002), Granetzny (2005), and Wu have similarly demonstrated benefits of SSRF in flail chest, including reductions in ventilator time, pneumonia rates, and ICU length of stay. A 2024 RCT randomising 403 patients to early fixation (within 48 hours) versus delayed surgery (beyond 48 hours) found that early intervention decreased hospital and ICU length of stay, ventilator duration, and inflammatory markers, though 30-day mortality was not significantly different between groups. The WSES/CWIS position paper, published in the World Journal of Emergency Surgery in late 2024, synthesised 287 studies and generated 39 graded position statements. The consensus was clear for flail chest: SSRF should be strongly considered, particularly in patients with respiratory failure and those failing to wean from mechanical ventilation.
Where the Controversy Lies: Non-Flail Fracture Patterns
The far more contentious question is whether SSRF benefits the much larger population of patients with severe but non-flail rib fracture patterns - typically defined as three or more bi-cortically displaced fractures without paradoxical chest wall movement. This is where the practice has expanded most aggressively and where the evidence base is most conflicted.
Pieracci and colleagues published a two-year prospective controlled study examining SSRF in patients with a variety of fracture patterns, including non-flail injuries. The results were striking: surgery was independently associated with a 76% decreased likelihood of respiratory failure and an 82% decreased likelihood of tracheostomy, alongside a five-day reduction in ventilator duration. But this was not a fully randomised study, and the selection of patients for surgery inevitably introduces confounders.
The picture became more complicated with the publication of Meyer and colleagues’ RCT in Annals of Surgery in 2023. This trial randomised 84 patients with severe chest wall injury (including radiographic flail segments without clinical flail, five or more consecutive fractures, or any fracture with bi-cortical displacement) to SSRF or non-operative management. The findings were sobering for proponents of surgery. Hospital length of stay was significantly greater in the SSRF group (rate ratio 1.48, 95% CI 1.17–1.88). ICU stay and ventilator days were similar between groups. At one month, patients who had undergone surgery reported greater impairment in mobility and self-care on the EQ-5D-5L quality of life instrument. The authors concluded that in severe chest wall injury - even with radiographic flail - SSRF did not provide quality of life benefit for up to six months.
Marasco’s Australian multicentre RCT reached a similar conclusion for non-ventilated patients with three or more painful or displaced rib fractures: no improvements in pain or quality of life at three and six months, although return-to-work rates did favour the operative group. Critics have noted the significant crossover rates in this trial, which may have diluted the treatment effect.
The Patient Selection Dilemma
The fundamental challenge, and the source of much of the controversy, is patient selection. The Chest Wall Injury Society’s ongoing multicentre non-flail RCT was designed precisely because of the uncertainty in this population. Their equipoise survey of practising trauma surgeons found that clinical opinion was most evenly divided - 50% recommending surgery, 50% not - for patients aged 18 to 75 with no or mild traumatic brain injury and two or more pulmonary derangements after adequate loco-regional analgesia. This near-perfect equipoise underscores just how unsettled the field remains.
Scoring systems have been developed to try to objectify the decision. The RibScore, a six-point radiographic scoring system, uses fracture characteristics to predict adverse pulmonary outcomes. A 2026 study of 452 patients who underwent SSRF found that adverse pulmonary outcomes increased linearly with RibScore and that observed complication rates after surgery were lower than those predicted by historical non-operative RibScore cohorts. However, the same data showed that RibScore should support risk stratification and shared decision-making rather than independently determining operative indications.
The geriatric population presents a particularly compelling case. Analysis of the National Trauma Data Bank identified over 93,000 elderly patients with rib fractures, of whom only 992 underwent SSRF. In the 65 to 79 age group, surgical fixation was associated with improved mortality regardless of the number of fractured ribs. The authors estimated that roughly 20,000 additional patients per year in the United States alone might meet inclusion criteria for SSRF - suggesting profound underutilisation. Yet the data from propensity-matched registries paint a more nuanced picture. A 2025 analysis of the German TraumaRegister DGU found that while SSRF reduced mortality in non-ventilated patients (1.6% versus controls), it was also associated with increased organ failure, longer ICU stays, and longer hospitalisation - an apparent paradox likely driven by selection bias and the difficulty of comparing like with like.
The Timing Question
Even among those who accept that SSRF is beneficial in selected patients, optimal timing remains debatable. Early surgery, typically defined as within 48 to 72 hours, avoids secondary complications such as inflammation, haematoma organisation, and early callus formation that increase the technical difficulty of late fixation. A multicentre retrospective study by Pieracci and colleagues found that late SSRF (3 to 10 days from admission) was associated with longer operative times, prolonged mechanical ventilation, increased pneumonia, and higher tracheostomy rates. The WSES/CWIS position paper acknowledges the growing evidence for early fixation but stops short of a definitive recommendation on timing, noting the need for further prospective data. The practical reality is that many patients with rib fractures are initially managed non-operatively and referred for surgery only when they fail to progress - creating a built-in delay that may itself worsen surgical outcomes.
What ATLS Candidates Need to Know
The ATLS course, now in its 10th edition, focuses on the primary and secondary survey management of chest trauma. It teaches recognition of flail chest as a life-threatening injury identified during the breathing assessment, the importance of adequate oxygenation and ventilation, and the principle that underlying pulmonary contusion - rather than the mechanical flail itself - is the primary driver of respiratory compromise. SSRF is not a core ATLS intervention; the course’s emphasis is on initial stabilisation rather than definitive operative management.
For the ATLS examination, candidates should be confident in several areas. First, the definition and recognition of flail chest and its physiological consequences, including paradoxical chest wall movement and the role of underlying contusion. Second, the initial management priorities: adequate analgesia (with an awareness that regional techniques such as epidural and paravertebral blocks are increasingly preferred over systemic opioids), supplemental oxygen, and ventilatory support as required. Third, that obligatory mechanical ventilation solely for the purpose of overcoming chest wall instability - so-called ‘internal pneumatic splinting’ - is now considered outdated practice.
Beyond the examination, however, candidates entering trauma practice should be aware that SSRF is an evolving and increasingly important component of definitive chest wall injury management. The 2025 ACS Best Practice Guidelines now include detailed recommendations for SSRF, including strong consideration in clinical flail chest, relative indications for three or more bi-cortically displaced fractures, and the principle that early assessment by a trained surgical team should be part of the admission workup. Understanding that the field is in active evolution - and that the question is increasingly not whether to fix ribs but which ribs, in which patients, and when - will serve candidates well in clinical practice and in viva examination discussion.
Synthesis: Where We Stand
The current evidence supports several conclusions with reasonable confidence. SSRF reduces morbidity and likely mortality in patients with flail chest, particularly those who are ventilator-dependent. Early fixation (within 72 hours) appears superior to delayed surgery. For the much larger population with severe non-flail fracture patterns, the data are genuinely conflicted, with some trials demonstrating benefit and others showing no advantage or even harm from surgery. Patient selection remains the critical unsolved problem, and the ongoing CWIS non-flail RCT may provide the definitive answer. The geriatric population may derive disproportionate benefit, but high-quality prospective data are still lacking. What is clear is that the era of treating all rib fractures with analgesia alone is receding. The challenge now is to define, with precision, the patient who will benefit from operative fixation and to ensure that surgery is delivered early, by trained teams, with appropriate infrastructure. For the ATLS candidate, the core principles of recognition, initial stabilisation, and ventilatory support remain paramount. But the landscape of definitive rib fracture management is being redrawn, and awareness of this evolving controversy is essential for any trauma practitioner.